Thank you to Janitronics Building Services for your continued support and sponsorship of all four of MassBio's Premier Mixers this year! If you're interested in sponsoring our Oktoberfest Mixer or Holiday Mixer, please reach out to [email protected].
MassBio
Biotechnology Research
Cambridge, Massachusetts 34,249 followers
Massachusetts is the State of Possible - the #1 life sciences cluster in the world - and we plan to keep it that way!
About us
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.
- Website
-
http://www.massbio.org
External link for MassBio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Nonprofit
- Founded
- 1985
Locations
-
Primary
700 Technology Sq
5th Floor
Cambridge, Massachusetts 02139, US
Employees at MassBio
-
Carolina Alarco
Biotech/Medtech Executive and Board Member, Strategic Consultant, Investment Banking, Angel Investor
-
Joel Kahn MD, NBC-HWC
Innovation driven health executive
-
Joseph Murphy
Founder and President at immunePCS, LLC
-
Rita McAteer
Accomplished marketing, communications and fundraising leader.
Updates
-
This edition of #FundingFriday is headlined by eGenesis, Inc.'s $191M Series D financing led by Lux Capital. #MassBioMember eGenesis, which has now raised about $450M, is the biotech behind the technology that enabled the first-ever pig-to-human kidney transplant earlier this year. More from Hannah Green in the BBJ: https://lnkd.in/d9cHXkf7. “This financing demonstrates the confidence that investors have in cross-species transplantation as a potential solution to the global organ crisis and in eGenesis as the leader in this sector,” eGenesis CEO Mike Curtis said in the announcement. “We are thrilled to work with Lux Capital and this world-class syndicate to advance our lead program to formal clinical trials. With this support, we are one step closer to bringing a solution to help patients suffering from organ failure.” All told, more than $236M in VC and other private funding was reported by A-Synaptic, CytoTronics, eGenesis, Prana Biosciences Inc., Savran Technologies Inc., Somite Therapeutics, and Superluminal Medicines Inc. over the last couple weeks.
-
Congratulations to the HDAX Therapeutics team on closing your $3.2M seed round! We are so proud to have played a small role in your journey through the #MassBioDrive program (https://lnkd.in/eGegQGcX), and you will always be a part of the #MassBio community. #patientdriven #accelerator #entrepreneurs #seedround #biotech
We’re excited to announce the first closing of our oversubscribed US$3.2 (CA$4.3) million seed round, led by SeedFolio, FACIT, and TIAP - Toronto Innovation Acceleration Partners, with participation from Eos BioInnovation, Ontario Centre of Innovation (OCI), Anges Québec, OBIO, and other institutional and private investors. Proceeds from this financing will support the company’s progress towards preclinical development candidate nomination and further advancement of its pipeline programs. Read more about the financing in our latest Press Release: https://lnkd.in/eMuEr-bw HDAX Therapeutics is pioneering next-gen HDAC6 targeting therapeutics to transform patient outcomes in neuropathies, cardiometabolic diseases and beyond. Learn more about our mission and innovations at https://hdaxtx.com/. #Seedfinancing #Fundraising #Milestone #Drugdiscovery #Biotech #Therapeutics #HDAC6 #Innovation
-
We are grateful for Dr. Laurie Glimcher’s leadership of Dana-Farber Cancer Institute and her commitment to patients, physician-scientists, and healthy equity. We also welcome Benjamin L. Ebert, MD, PhD as the new president and CEO. https://lnkd.in/gn4Ekd77 #patientdriven We appreciate all of Laurie's contributions, including being a panelist at State of Possible in 2023 and having a featured quote in this year's Industry Snapshot (below) regarding NIH funding.
-
School buses are on the roads, the mornings are cooler, and pumpkin spice is back at Dunks. With the flip of the calendar to September, we're back with another #WelcomeWednesday to introduce the latest members of the MassBio Community: 🧪 ACM Global Laboratories has been a recognized leader in global clinical trial testing services. Through wholly-owned facilities and partner laboratories, ACM supports clinical trials in more than 65 countries around the globe. 🎀 Cancer Support Community, Massachusetts – Norwell, MA CSC Massachusetts’ mission is to uplift and strengthen people impacted by cancer by providing support, fostering compassionate communities, and breaking down barriers to care. 🦠 Cell X Technologies, Woburn MA Cell X is revolutionizing cell processing. At the core of this revolution lies its transformative Celligent™ platform – a novel combination of robotics, imaging, and artificial intelligence that enables innovators to develop consistent, reproducible, and scalable GMP-compliant processes. 🏛️ ELIQUENT Life Sciences, Washington, DC ELIQUENT brings clarity to regulatory complexity. They are expert consultants delivering the answers and solutions that life sciences innovators need to gain and maintain market authorization for their products. 💼 JVS Boston – Boston, MA JVS Boston empowers individuals facing barriers to employment to find economic success. JVS offers over 35 different programs to help individuals from all backgrounds build their skills, advance their education, and launch meaningful careers. 💊 Meiji Pharma, USA – Cambridge, MA From prevention to treatment, Meiji is improving quality of care and lowering drug costs for millions of patients worldwide. 💉 OmniaBio – Ontario, CA Next-generation cell and gene therapies (CGTs) are OmniaBio's specialty. OmniaBio's directive of collaborative partnership converges with deep industry experience and innovation using the latest technologies to drive the future of cell and gene therapy manufacturing. 📝 Pioneer GMP Consulting – Newton, MA Pioneer GMP Consulting will apply critical-thinking to current industry practices to re-design GMP-solutions that are business-minded, cost-effective, and sustainable. 🔬 Rigaku Pharmaceutical Technologies, Cambridge MA Rigaku’s mission is to contribute to the enhancement of humanity through scientific and technological development. ⚗️ Topo Therapeutics, Chestnut Hill, MA #MassBioMembers
-
Announcing Novo Nordisk #PharmaDay® on October 29! Join us for Novo Nordisk’s open information session on the latest insights on their R&D strategy, target therapeutic areas, and partnering capabilities. A networking reception will follow this session at the #MassBioHub. Groundbreaking innovators across early research and discovery stage of development with any therapeutic modality are encouraged to apply for a one-on-one meeting with Novo Nordisk representatives during the day. Their priority therapeutic areas include: - Diabetes - Obesity - Other chronic diseases (Cardiovascular Diseases, MASH/NASH, CKD, Rare Blood Disorders) Please apply for a 1:1 by September 16: https://lnkd.in/g324cf8T Interested in joining us and learning more about Novo Nordisk? Learn more and register here: https://lnkd.in/gKw-yKX9
-
The biopharma industry is a key sector and economic driver in Massachusetts, and the partnership between industry and state government is at the very foundation of its success. Read more in the 2024 MassBio Industry Snapshot: https://lnkd.in/e8Wdfkzy. #MassBioIndustrySnapshot | Ron Mariano | Massachusetts Executive Office of Economic Development (EOED) | Yvonne Hao
-
Looking for some news to read at the beach or on the lake? We've got you covered: 💰 Boston-biotech NextRNA Therapeutics has signed a deal worth up to $547M with Bayer to work together on advancing two oncology programs. https://lnkd.in/e3GRKFaX 🤝🏻 Quotient Therapeutics, co-located in the two Cambridges, has been brought into the partnership between Flagship Pioneering and Pfizer. https://lnkd.in/e-GvThW7 ❤️ Alnylam Pharmaceuticals’ vutrisiran may boost survival in patients with a heart muscle disease who are already taking a popular background therapy. https://lnkd.in/eeYEhY5B ✔️ Earlier this month, Servier Pharmaceuticals won an FDA approval for its once-daily pill for glioma patients, “an enormous leap forward in cancer care.” https://lnkd.in/en4GagfU 🗠 Armed with clinical-stage data, Zenas BioPharma and Bicara Therapeutics both fit the profile of biotechs that have successfully pulled off IPOs this year. https://lnkd.in/g8G6vEBZ ♨️ Lexington, a top #lifesciences cluster in MA, exploring geothermal energy systems to power new green lab development. https://lnkd.in/eUN55ACc 🐶 Beverly-based Akston Biosciences Corporation is co-developing an immunotherapy to treat cancer in dogs with Purdue University. https://lnkd.in/ey5KCfDC Boston Business Journal | Endpoints News | BioPharma Dive | Banker & Tradesman
-
Our Waltham Regional Mixer was last week at the Mighty Squirrel Brewing Company. It was wonderful to see our #MassBioMember community for an evening connecting with colleagues, networking with other #lifesciences professionals in the area, and enjoying some fun! Thank you to our sponsors: Thermo Fisher Scientific | Vertex Pharmaceuticals | Evaluate Ltd | Mispro | Harvard Pilgrim Health Care | Societal™ CDMO If you missed us, we hope to see you at one of our future events: https://lnkd.in/eWKF5hDB
-
+2
-
Excellent article shared from Hannah Green on the potential local impacts of the #BiosecureAct quoting several #MassBioMembers. The Boston Business Journal also issued an editorial about #biomanufacturing's future in Massachusetts that's worth a #FridayRead: https://lnkd.in/e8aG7AHi. #CDMO #CRO
CEO & President, MassBio | Chair, Bioversity | Board, The Boston Foundation | Vice Chair, American Cancer Society (ACS) Eastern New England | Board, MassBioEd Foundation
We must find a way to address these national security concerns without hindering the delivery of medicines to patients in need. As Congressman Jake Auchincloss says, a 'carrot and stick' approach. This is a huge opportunity for Massachusetts to expand its manufacturing capabilities for the #lifesciences industry. We need to be ready to meet the federal government halfway to ensure some of the expanded domestic #biomanufacturing infrastructure is built here in Massachusetts. We can't afford to upend a supply chain that serves patients without delivering the resources to fill the gaping holes. https://lnkd.in/exv_YjNr